A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

The emergence of antigenically distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased transmissibility is a public health threat. Some of these variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies, wh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:bioRxiv
Egile Nagusiak: Schmitz, Aaron J., Turner, Jackson S., Liu, Zhuoming, Aziati, Ishmael D., Chen, Rita E., Joshi, Astha, Bricker, Traci L., Darling, Tamarand L., Adelsberg, Daniel C., Alsoussi, Wafaa B., Case, James Brett, Lei, Tingting, Thapa, Mahima, Amanat, Fatima, O’Halloran, Jane A., Shi, Pei-Yong, Presti, Rachel M., Krammer, Florian, Bajic, Goran, Whelan, Sean P.J., Diamond, Michael S., Boon, Adrianus C. M., Ellebedy, Ali H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cold Spring Harbor Laboratory 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010723/
https://ncbi.nlm.nih.gov/pubmed/33791696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.03.24.436864
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak